Lipids & metabolic liver disease

Remnant cholesterol, but not low‐density lipoprotein cholesterol, is associated with intra‐pancreatic fat deposition

Diabetes Obes MetabPublished Cross-sectional study

Authors' conclusion

Components of the lipid panel have different associations with IPFD. This may open up new opportunities for improving outcomes in people at high risk for cardiovascular diseases (who have normal low-density lipoprotein cholesterol) by reducing IPFD.

Study context

Population
Participants undergoing abdominal MRI on the same 3.0-Tesla scanner with fasting lipid panel
Participants
348 participants
Outcome
Associations of lipid panel components (and derivatives) with intra-pancreatic fat deposition (IPFD)
Methodological detailslinear regression adjusted for age, sex, ethnicity, BMI, FPG, HOMA-IR and liver fat deposition
  • Linear regression adjusted for age, sex, ethnicity, BMI, FPG, HOMA-IR and liver fat deposition

Main finding

As reported in the abstract

Association with total IPFD (most adjusted model)
Remnant cholesterol positively associated with total intra-pancreatic fat deposition (IPFD)
P = 0.010
TG positively associated with total IPFD
P = 0.008
HDL-C negatively associated with total IPFD
P = 0.001
Remnant cholesterol explained the greatest proportion of variance in total IPFD
9.9%

Observational data: associations, not effects.

Original publication

Remnant cholesterol, but not low‐density lipoprotein cholesterol, is associated with intra‐pancreatic fat deposition. Diabetes Obes Metab. Published 2 August 2023. doi:10.1111/dom.15233

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.